 | • レポートコード：QYR9ST06181 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、新生児結膜炎治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経口、局所、筋肉内及び静脈内に、用途別には、病院薬局、小売薬局、その他にセグメント区分し、新生児結膜炎治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・新生児結膜炎治療薬の世界市場概要 ・新生児結膜炎治療薬の製造コスト構成分析 ・新生児結膜炎治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・新生児結膜炎治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・新生児結膜炎治療薬のセグメント分析（種類別） （経口、局所、筋肉内及び静脈内） ・新生児結膜炎治療薬のセグメント分析（用途別） （病院薬局、小売薬局、その他） ・新生児結膜炎治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Merck & Co. Inc.、Akorn Inc、Pfizer、Bayer AG） ・新生児結膜炎治療薬の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
Neonatal Conjunctivitis is also known as Opthalmia Neonatorum. Neonatal conjunctivitis manifests in the infant within the first 28 days of being born.
The global Neonatal Conjunctivitis Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Neonatal Conjunctivitis Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neonatal Conjunctivitis Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Neonatal Conjunctivitis Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Neonatal Conjunctivitis Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Merck & Co. Inc.
Akorn Inc
Pfizer
Bayer AG
…
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Oral
Topical
Intramuscular and Intravenous
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others
Table of Contents
Executive Summary
1 Industry Overview of Neonatal Conjunctivitis Therapeutics
1.1 Definition of Neonatal Conjunctivitis Therapeutics
1.2 Neonatal Conjunctivitis Therapeutics Segment by Type
1.2.1 Global Neonatal Conjunctivitis Therapeutics Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Oral
1.2.3 Topical
1.2.4 Intramuscular and Intravenous
1.3 Neonatal Conjunctivitis Therapeutics Segment by Applications
1.3.1 Global Neonatal Conjunctivitis Therapeutics Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Global Neonatal Conjunctivitis Therapeutics Overall Market
1.4.1 Global Neonatal Conjunctivitis Therapeutics Revenue (2014-2025)
1.4.2 Global Neonatal Conjunctivitis Therapeutics Production (2014-2025)
1.4.3 North America Neonatal Conjunctivitis Therapeutics Status and Prospect (2014-2025)
1.4.4 Europe Neonatal Conjunctivitis Therapeutics Status and Prospect (2014-2025)
1.4.5 China Neonatal Conjunctivitis Therapeutics Status and Prospect (2014-2025)
1.4.6 Japan Neonatal Conjunctivitis Therapeutics Status and Prospect (2014-2025)
1.4.7 Southeast Asia Neonatal Conjunctivitis Therapeutics Status and Prospect (2014-2025)
1.4.8 India Neonatal Conjunctivitis Therapeutics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Neonatal Conjunctivitis Therapeutics
2.3 Manufacturing Process Analysis of Neonatal Conjunctivitis Therapeutics
2.4 Industry Chain Structure of Neonatal Conjunctivitis Therapeutics
3 Development and Manufacturing Plants Analysis of Neonatal Conjunctivitis Therapeutics
3.1 Capacity and Commercial Production Date
3.2 Global Neonatal Conjunctivitis Therapeutics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Neonatal Conjunctivitis Therapeutics
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Neonatal Conjunctivitis Therapeutics Production and Capacity Analysis
4.2 Neonatal Conjunctivitis Therapeutics Revenue Analysis
4.3 Neonatal Conjunctivitis Therapeutics Price Analysis
4.4 Market Concentration Degree
5 Neonatal Conjunctivitis Therapeutics Regional Market Analysis
5.1 Neonatal Conjunctivitis Therapeutics Production by Regions
5.1.1 Global Neonatal Conjunctivitis Therapeutics Production by Regions
5.1.2 Global Neonatal Conjunctivitis Therapeutics Revenue by Regions
5.2 Neonatal Conjunctivitis Therapeutics Consumption by Regions
5.3 North America Neonatal Conjunctivitis Therapeutics Market Analysis
5.3.1 North America Neonatal Conjunctivitis Therapeutics Production
5.3.2 North America Neonatal Conjunctivitis Therapeutics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Neonatal Conjunctivitis Therapeutics Import and Export
5.4 Europe Neonatal Conjunctivitis Therapeutics Market Analysis
5.4.1 Europe Neonatal Conjunctivitis Therapeutics Production
5.4.2 Europe Neonatal Conjunctivitis Therapeutics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Neonatal Conjunctivitis Therapeutics Import and Export
5.5 China Neonatal Conjunctivitis Therapeutics Market Analysis
5.5.1 China Neonatal Conjunctivitis Therapeutics Production
5.5.2 China Neonatal Conjunctivitis Therapeutics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Neonatal Conjunctivitis Therapeutics Import and Export
5.6 Japan Neonatal Conjunctivitis Therapeutics Market Analysis
5.6.1 Japan Neonatal Conjunctivitis Therapeutics Production
5.6.2 Japan Neonatal Conjunctivitis Therapeutics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Neonatal Conjunctivitis Therapeutics Import and Export
5.7 Southeast Asia Neonatal Conjunctivitis Therapeutics Market Analysis
5.7.1 Southeast Asia Neonatal Conjunctivitis Therapeutics Production
5.7.2 Southeast Asia Neonatal Conjunctivitis Therapeutics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Neonatal Conjunctivitis Therapeutics Import and Export
5.8 India Neonatal Conjunctivitis Therapeutics Market Analysis
5.8.1 India Neonatal Conjunctivitis Therapeutics Production
5.8.2 India Neonatal Conjunctivitis Therapeutics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Neonatal Conjunctivitis Therapeutics Import and Export
6 Neonatal Conjunctivitis Therapeutics Segment Market Analysis (by Type)
6.1 Global Neonatal Conjunctivitis Therapeutics Production by Type
6.2 Global Neonatal Conjunctivitis Therapeutics Revenue by Type
6.3 Neonatal Conjunctivitis Therapeutics Price by Type
7 Neonatal Conjunctivitis Therapeutics Segment Market Analysis (by Application)
7.1 Global Neonatal Conjunctivitis Therapeutics Consumption by Application
7.2 Global Neonatal Conjunctivitis Therapeutics Consumption Market Share by Application (2014-2019)
8 Neonatal Conjunctivitis Therapeutics Major Manufacturers Analysis
8.1 Merck & Co. Inc.
8.1.1 Merck & Co. Inc. Neonatal Conjunctivitis Therapeutics Production Sites and Area Served
8.1.2 Merck & Co. Inc. Product Introduction, Application and Specification
8.1.3 Merck & Co. Inc. Neonatal Conjunctivitis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Akorn Inc
8.2.1 Akorn Inc Neonatal Conjunctivitis Therapeutics Production Sites and Area Served
8.2.2 Akorn Inc Product Introduction, Application and Specification
8.2.3 Akorn Inc Neonatal Conjunctivitis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Pfizer
8.3.1 Pfizer Neonatal Conjunctivitis Therapeutics Production Sites and Area Served
8.3.2 Pfizer Product Introduction, Application and Specification
8.3.3 Pfizer Neonatal Conjunctivitis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Bayer AG
8.4.1 Bayer AG Neonatal Conjunctivitis Therapeutics Production Sites and Area Served
8.4.2 Bayer AG Product Introduction, Application and Specification
8.4.3 Bayer AG Neonatal Conjunctivitis Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
9 Development Trend of Analysis of Neonatal Conjunctivitis Therapeutics Market
9.1 Global Neonatal Conjunctivitis Therapeutics Market Trend Analysis
9.1.1 Global Neonatal Conjunctivitis Therapeutics Market Size (Volume and Value) Forecast 2019-2025
9.2 Neonatal Conjunctivitis Therapeutics Regional Market Trend
9.2.1 North America Neonatal Conjunctivitis Therapeutics Forecast 2019-2025
9.2.2 Europe Neonatal Conjunctivitis Therapeutics Forecast 2019-2025
9.2.3 China Neonatal Conjunctivitis Therapeutics Forecast 2019-2025
9.2.4 Japan Neonatal Conjunctivitis Therapeutics Forecast 2019-2025
9.2.5 Southeast Asia Neonatal Conjunctivitis Therapeutics Forecast 2019-2025
9.2.6 India Neonatal Conjunctivitis Therapeutics Forecast 2019-2025
9.3 Neonatal Conjunctivitis Therapeutics Market Trend (Product Type)
9.4 Neonatal Conjunctivitis Therapeutics Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Neonatal Conjunctivitis Therapeutics Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Neonatal Conjunctivitis Therapeutics
Table Global Neonatal Conjunctivitis Therapeutics Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Neonatal Conjunctivitis Therapeutics Production Market Share by Types in 2018
Figure Oral Product Picture
Figure Topical Product Picture
Figure Intramuscular and Intravenous Product Picture
Table Global Neonatal Conjunctivitis Therapeutics Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Neonatal Conjunctivitis Therapeutics Consumption Market Share by Applications in 2018
Figure Hospital Pharmacies
Figure Retail Pharmacies
Figure Others
Figure Global Neonatal Conjunctivitis Therapeutics Revenue (Million USD) (2014-2025)
Figure Global Neonatal Conjunctivitis Therapeutics Production (K Units) (2014-2025)
Figure North America Neonatal Conjunctivitis Therapeutics Market Size (Million USD) (2014-2025)
Figure Europe Neonatal Conjunctivitis Therapeutics Market Size (Million USD) (2014-2025)
Figure China Neonatal Conjunctivitis Therapeutics Market Size (Million USD) (2014-2025)
Figure Japan Neonatal Conjunctivitis Therapeutics Market Size (Million USD) (2014-2025)
Figure Southeast Asia Neonatal Conjunctivitis Therapeutics Market Size (Million USD) (2014-2025)
Figure India Neonatal Conjunctivitis Therapeutics Market Size (Million USD) (2014-2025)
Table Neonatal Conjunctivitis Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Neonatal Conjunctivitis Therapeutics in 2018
Figure Manufacturing Process Analysis of Neonatal Conjunctivitis Therapeutics
Figure Industry Chain Structure of Neonatal Conjunctivitis Therapeutics
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Neonatal Conjunctivitis Therapeutics Manufacturing Plants Distribution
Table Neonatal Conjunctivitis Therapeutics Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Neonatal Conjunctivitis Therapeutics Capacity (K Units) of Major Manufacturers (2014-2019)
Table Neonatal Conjunctivitis Therapeutics Production (K Units) of Major Manufacturers (2014-2019)
Table Neonatal Conjunctivitis Therapeutics Production Market Share of Major Manufacturers (2014-2019)
Figure Neonatal Conjunctivitis Therapeutics Production Share by Manufacturers in 2018
Table Neonatal Conjunctivitis Therapeutics Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Neonatal Conjunctivitis Therapeutics Revenue Market Share of Major Manufacturers (2014-2019)
Figure Neonatal Conjunctivitis Therapeutics Revenue Share by Manufacturers in 2018
Table Neonatal Conjunctivitis Therapeutics Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Neonatal Conjunctivitis Therapeutics Production by Regions 2014-2019 (K Units)
Table Global Neonatal Conjunctivitis Therapeutics Production Market Share by Regions 2014-2019
Figure Global Neonatal Conjunctivitis Therapeutics Production Market Share by Regions in 2018
Table Global Neonatal Conjunctivitis Therapeutics Revenue by Regions 2014-2019 (Million USD)
Table Global Neonatal Conjunctivitis Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Neonatal Conjunctivitis Therapeutics Revenue Market Share by Regions in 2018
Table Global Neonatal Conjunctivitis Therapeutics Consumption by Regions 2014-2019 (K Units)
Table Global Neonatal Conjunctivitis Therapeutics Consumption Market Share by Regions 2014-2019
Figure North America Neonatal Conjunctivitis Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure North America Neonatal Conjunctivitis Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table North America Neonatal Conjunctivitis Therapeutics Production, Consumption Import and Export (K Units)
Figure Europe Neonatal Conjunctivitis Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure Europe Neonatal Conjunctivitis Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Neonatal Conjunctivitis Therapeutics Production, Consumption Import and Export (K Units)
Figure China Neonatal Conjunctivitis Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure China Neonatal Conjunctivitis Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table China Neonatal Conjunctivitis Therapeutics Production, Consumption Import and Export (K Units)
Figure Japan Neonatal Conjunctivitis Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure Japan Neonatal Conjunctivitis Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Neonatal Conjunctivitis Therapeutics Production, Consumption Import and Export (K Units)
Figure Southeast Asia Neonatal Conjunctivitis Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Neonatal Conjunctivitis Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Neonatal Conjunctivitis Therapeutics Production, Consumption Import and Export (K Units)
Figure India Neonatal Conjunctivitis Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure India Neonatal Conjunctivitis Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table India Neonatal Conjunctivitis Therapeutics Production, Consumption Import and Export (K Units)
Figure Global Consumption Neonatal Conjunctivitis Therapeutics Market Share by Application (2014-2019)
Figure Global Value (Consumption) Neonatal Conjunctivitis Therapeutics Market Share by Application (2014-2019)
Table Merck & Co. Inc. Neonatal Conjunctivitis Therapeutics Production Sites and Area Served
Table Merck & Co. Inc. Neonatal Conjunctivitis Therapeutics Product Introduction, Application and Specification
Table Merck & Co. Inc. Neonatal Conjunctivitis Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck & Co. Inc. Neonatal Conjunctivitis Therapeutics Production Growth Rate (2014-2019)
Table Merck & Co. Inc. Neonatal Conjunctivitis Therapeutics Production Market Share (2014-2019)
Figure Merck & Co. Inc. Neonatal Conjunctivitis Therapeutics Revenue Market Share (2014-2019)
Table Merck & Co. Inc. Neonatal Conjunctivitis Therapeutics Main Business and Markets Served
Table Akorn Inc Neonatal Conjunctivitis Therapeutics Production Sites and Area Served
Table Akorn Inc Neonatal Conjunctivitis Therapeutics Product Introduction, Application and Specification
Table Akorn Inc Neonatal Conjunctivitis Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Akorn Inc Neonatal Conjunctivitis Therapeutics Production Growth Rate (2014-2019)
Table Akorn Inc Neonatal Conjunctivitis Therapeutics Production Market Share (2014-2019)
Figure Akorn Inc Neonatal Conjunctivitis Therapeutics Revenue Market Share (2014-2019)
Table Akorn Inc Neonatal Conjunctivitis Therapeutics Main Business and Markets Served
Table Pfizer Neonatal Conjunctivitis Therapeutics Production Sites and Area Served
Table Pfizer Neonatal Conjunctivitis Therapeutics Product Introduction, Application and Specification
Table Pfizer Neonatal Conjunctivitis Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Neonatal Conjunctivitis Therapeutics Production Growth Rate (2014-2019)
Table Pfizer Neonatal Conjunctivitis Therapeutics Production Market Share (2014-2019)
Figure Pfizer Neonatal Conjunctivitis Therapeutics Revenue Market Share (2014-2019)
Table Pfizer Neonatal Conjunctivitis Therapeutics Main Business and Markets Served
Table Bayer AG Neonatal Conjunctivitis Therapeutics Production Sites and Area Served
Table Bayer AG Neonatal Conjunctivitis Therapeutics Product Introduction, Application and Specification
Table Bayer AG Neonatal Conjunctivitis Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer AG Neonatal Conjunctivitis Therapeutics Production Growth Rate (2014-2019)
Table Bayer AG Neonatal Conjunctivitis Therapeutics Production Market Share (2014-2019)
Figure Bayer AG Neonatal Conjunctivitis Therapeutics Revenue Market Share (2014-2019)
Table Bayer AG Neonatal Conjunctivitis Therapeutics Main Business and Markets Served
Figure Global Neonatal Conjunctivitis Therapeutics Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Neonatal Conjunctivitis Therapeutics Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Neonatal Conjunctivitis Therapeutics Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Neonatal Conjunctivitis Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Neonatal Conjunctivitis Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Neonatal Conjunctivitis Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Neonatal Conjunctivitis Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Neonatal Conjunctivitis Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Neonatal Conjunctivitis Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Neonatal Conjunctivitis Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Neonatal Conjunctivitis Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Neonatal Conjunctivitis Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Neonatal Conjunctivitis Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Neonatal Conjunctivitis Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Neonatal Conjunctivitis Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Neonatal Conjunctivitis Therapeutics by Type (2019-2025)
Table Global Consumption (K Units) of Neonatal Conjunctivitis Therapeutics by Application (2019-2025)
Table Neonatal Conjunctivitis Therapeutics Distributors List
Table Neonatal Conjunctivitis Therapeutics Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の結膜炎治療薬市場：専門的調査 Conjunctivitis is an inflammation or swelling of the conjunctiva. The global Conjunctivitis Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Conjunctivitis Therapeutics volume …- 世界の結膜炎治療薬市場：専門的調査 Conjunctivitis is an inflammation or swelling of the conjunctiva. The global Conjunctivitis Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Conjunctivitis Therapeutics volume …
- 細菌性結膜炎薬の世界市場：インサイト・予測 Conjunctivitis is an inflammation of the conjunctiva - the clear membrane that covers the outermost layer of an eye and the inner surface of eyelids. Conjunctivitis is segmented into three major categories: infective (viral and bacterial), allergic, and irritant (chemical). Bacterial conjunctivitis …
- 世界のアレルギー性結膜炎治療市場：専門的調査 Swelling of conjunctiva (tissue covering white portion of eye) due to allergy is known as allergic conjunctivitis. Allergic conjunctivitis is caused due to allergens in patients such as household dust, mold spores, pollen from trees and grass, chemical scents (e.g., household detergents or perfume) …
- 世界の急性及び慢性アレルギー性結膜炎治療市場：専門的調査 Swelling of conjunctiva (tissue covering white portion of eye) due to allergy is known as allergic conjunctivitis. Allergic conjunctivitis is caused due to allergens in patients such as household dust, mold spores, pollen from trees and grass, chemical scents (e.g., household detergents or perfume) …